As the number of iPSC-based therapies in clinical development is increasing, the industry is seeing significant advancement following decades of the industry’s iPSC development efforts.

In this webinar transcript, which was hosted on Cell & Gene Therapy Insights in March 2024, industry experts delve into the critical aspects of reshaping the future landscape of iPSC-based therapies.

The topics discussed include:

• Strategies to expedite therapy development and accelerate speed to market
• Evaluation of existing licensing and royalty stacking paradigm in iPSC technology
• Examine existing product characterization best practices
• Debate the necessary clean room environments and the impact on manufacturing efficiency and quality

Panelists:
Melissa Carpenter, Lise Munsie, Kim Raineri, and Bruno Marques